AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder.  The Institute for Clinical and… Read More »

Delta variant rising in Black communities, experts say get vaccinated

Loading the player… Health experts and local leaders nationwide continue to encourage COVID-19 vaccinations as new data shows an increase in delta variant cases in Black communities. Martin Luther King, Jr. Community Healthcare (MLKCH), one of Los Angeles’ leading medical institutions, released data on July 19 via Facebook showing that Black Americans are being hit… Read More »

Growing cyberattacks on hospitals may soon hit bottom lines, patient care: Fitch

Dive Brief: U.S. hospitals and healthcare systems have been under such relentless cyberattacks in recent months that it is beginning to be a threat to their bottom lines, according to a new report from Fitch Ratings. Fitch says the issue has become increasingly serious over the past 18 months, citing data from the firm Bitglass… Read More »